Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Synopses

Life-Threatening SARS-CoV-2–Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022–2024 [PDF - 2.18 MB - 11 pages]
M. Kasai et al.

SARS-CoV-2 infections in children occasionally manifest with severe neurologic signs. We report a case series of life-threatening encephalopathy associated with SARS-CoV-2 in 25 children in Australia, Japan, Singapore, and Taiwan during February 2022–January 2024. All children had severe encephalopathy develop, characterized by rapidly progressive cerebral edema, conditions known as acute shock with encephalopathy and multiorgan failure or acute fulminant cerebral edema. Among the 25 patients, 22 (88%) eventually died; 11 (44%) children died within 24 hours of hospitalization. In addition, 18 (72%) had illness manifest with shock, and 14 (56%) had multiorgan failure develop within 6 hours of neurologic onset. Serum concentrations of cytokines/chemokines including interleukin 6 and tumor necrosis factor-α were significantly higher within 24 hours of onset than for controls. SARS-CoV-2–associated encephalopathy cases such as those described here represent an emerging neurologic crisis with high mortality rate resulting from rapidly progressive brain edema and multiorgan failure.

EID Kasai M, Sakuma H, Suzuki M, Nishiyama M, Kawata N, Lin J, et al. Life-Threatening SARS-CoV-2–Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022–2024. Emerg Infect Dis. 2026;32(2):169-179. https://doi.org/10.3201/eid3202.250549
AMA Kasai M, Sakuma H, Suzuki M, et al. Life-Threatening SARS-CoV-2–Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022–2024. Emerging Infectious Diseases. 2026;32(2):169-179. doi:10.3201/eid3202.250549.
APA Kasai, M., Sakuma, H., Suzuki, M., Nishiyama, M., Kawata, N., Lin, J....Takanashi, J. (2026). Life-Threatening SARS-CoV-2–Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022–2024. Emerging Infectious Diseases, 32(2), 169-179. https://doi.org/10.3201/eid3202.250549.
Research

Predictors of Fatal Outcomes among Pediatric Patients Hospitalized for Rocky Mountain Spotted Fever, Sonora, Mexico, 2004–2024 [PDF - 1.20 MB - 11 pages]
S. Bellman et al.

The tickborne disease Rocky Mountain spotted fever (RMSF) remains life-threatening among children in northern Mexico. We retrospectively investigated 500 pediatric RMSF patients hospitalized in Sonora during 2004–2024. We analyzed clinical, laboratory, and sociodemographic data to identify predictors of fatality by using descriptive statistics and multivariable logistic regression. We found that the overall case-fatality rate was 19.8%, decreasing over time from 31.4% (2004–2013) to 14.5% (2014–2024). Fatal outcomes were associated with delayed doxycycline treatment (>5 days after symptom onset), older age, Indigenous background, and abnormal laboratory markers. Among survivors, 16% had life-altering sequelae, including amputations and neurologic deficits. Cases occurred year-round, predominantly in urban settings. Timely doxycycline administration remains a critical factor in reducing mortality rates. Vulnerable populations, including persons living in poverty, children >10 years of age, and Indigenous communities, require targeted interventions. Strengthening early diagnosis and understanding mechanisms underlying severe disease and death could improve RMSF outcomes in endemic regions.

EID Bellman S, McCoy KD, Enriquez D, Romo P, Hwang J, Weimer K, et al. Predictors of Fatal Outcomes among Pediatric Patients Hospitalized for Rocky Mountain Spotted Fever, Sonora, Mexico, 2004–2024. Emerg Infect Dis. 2026;32(2):180-190. https://doi.org/10.3201/eid3202.251223
AMA Bellman S, McCoy KD, Enriquez D, et al. Predictors of Fatal Outcomes among Pediatric Patients Hospitalized for Rocky Mountain Spotted Fever, Sonora, Mexico, 2004–2024. Emerging Infectious Diseases. 2026;32(2):180-190. doi:10.3201/eid3202.251223.
APA Bellman, S., McCoy, K. D., Enriquez, D., Romo, P., Hwang, J., Weimer, K....Álvarez-Hernández, G. (2026). Predictors of Fatal Outcomes among Pediatric Patients Hospitalized for Rocky Mountain Spotted Fever, Sonora, Mexico, 2004–2024. Emerging Infectious Diseases, 32(2), 180-190. https://doi.org/10.3201/eid3202.251223.

Leptotrombidium imphalum Chiggers as Vector for Scrub Typhus in Human Settlements, India, 2022–2023 [PDF - 1.76 MB - 11 pages]
C. S. Devamani et al.

Scrub typhus is a common bacterial infection in many parts of Asia. The causative agent, Orientia tsutsugamushi, is transmitted by trombiculid mite (chigger) larvae that require small mammals as maintaining hosts. We studied the prevalence of O. tsutsugamushi infection in mites and small mammals in villages and land surrounding them in South India to determine high-risk settings. We identified 12,431 mite larvae on 883 small mammals, 32% of which were bandicoot rats, 31% black rats, and 31% Asian house shrews. Leptotrombidium imphalum was the most common mite species and the only species associated with O. tsutsugamushi infection (prevalence 3.6%). Orientia infection increased with mite population size on a host. Host numbers, the L. imphalum index, and the prevalence of Orientia infection in chiggers were considerably higher within human settlements than in surrounding fields, suggesting that most human scrub typhus infection occurs inside villages rather than during agricultural work.

EID Devamani CS, Alexander N, Kumlert R, Makepeace BL, Morand S, Cameron M, et al. Leptotrombidium imphalum Chiggers as Vector for Scrub Typhus in Human Settlements, India, 2022–2023. Emerg Infect Dis. 2026;32(2):191-201. https://doi.org/10.3201/eid3202.251170
AMA Devamani CS, Alexander N, Kumlert R, et al. Leptotrombidium imphalum Chiggers as Vector for Scrub Typhus in Human Settlements, India, 2022–2023. Emerging Infectious Diseases. 2026;32(2):191-201. doi:10.3201/eid3202.251170.
APA Devamani, C. S., Alexander, N., Kumlert, R., Makepeace, B. L., Morand, S., Cameron, M....Schmidt, W. (2026). Leptotrombidium imphalum Chiggers as Vector for Scrub Typhus in Human Settlements, India, 2022–2023. Emerging Infectious Diseases, 32(2), 191-201. https://doi.org/10.3201/eid3202.251170.

Using Routine Surveillance Data to Assess Dengue Virus Transmission Risk in Travelers Returning to the United States [PDF - 2.19 MB - 9 pages]
K. Rysava et al.

Dengue virus poses a growing global health threat, yet inconsistent local surveillance limits global risk assessments. We analyzed 10,530 travel-associated dengue cases among US travelers reported to ArboNET during January 2010–April 2024, involving travel to 128 countries. By using negative binomial and Poisson models, we developed country-specific thresholds (75th, 80th, 90th percentiles) to identify elevated travel-associated dengue risk. We applied a >10-case threshold in a 3-month period to improve specificity. The final dual-criteria method accurately identified high-risk periods, including sustained transmission in countries with limited official reporting, such as Cuba in 2022–2023. Threshold comparisons revealed a tradeoff between early detection and overclassification, whereas real-time and retrospective assessments revealed consistent high-risk signals. This traveler-based approach offers a timely, complementary method for travel-associated dengue risk detection, although timeliness might be reduced if reporting delays increase beyond our observations. Our findings support integrating travel surveillance into global dengue monitoring and preparedness efforts.

EID Rysava K, Madewell ZJ, Thayer MB, Sánchez-González L, Muniz-Rodriguez K, Brown A, et al. Using Routine Surveillance Data to Assess Dengue Virus Transmission Risk in Travelers Returning to the United States. Emerg Infect Dis. 2026;32(2):202-210. https://doi.org/10.3201/eid3202.251217
AMA Rysava K, Madewell ZJ, Thayer MB, et al. Using Routine Surveillance Data to Assess Dengue Virus Transmission Risk in Travelers Returning to the United States. Emerging Infectious Diseases. 2026;32(2):202-210. doi:10.3201/eid3202.251217.
APA Rysava, K., Madewell, Z. J., Thayer, M. B., Sánchez-González, L., Muniz-Rodriguez, K., Brown, A....Johansson, M. A. (2026). Using Routine Surveillance Data to Assess Dengue Virus Transmission Risk in Travelers Returning to the United States. Emerging Infectious Diseases, 32(2), 202-210. https://doi.org/10.3201/eid3202.251217.

Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019 [PDF - 6.32 MB - 14 pages]
A. N. Duarte-Neto et al.

Yellow fever (YF) mainly causes severe hepatitis; data on pulmonary pathology remain limited. We investigated respiratory tract pathology in 73 fatal YF cases during the 2017–2019 epidemic in São Paulo, Brazil. All patients died from YF-related fulminant hepatitis. Autopsies revealed frequent tracheitis (91%), pulmonary edema and hemorrhage (100%), diffuse alveolar damage (84%), secondary pneumonia (84%), and bronchoaspiration (60%). Microabscesses, thrombi, and hemophagocytosis were also observed. In 5 cases of vaccine-associated viscerotropic disease, hemorrhage and diffuse alveolar damage were prominent. We detected antigens of YF virus in all cases and viral RNA in 94%. Molecular analysis identified bacterial and fungal pathogens in pneumonia, including gram-negative bacilli, Candida spp., and Aspergillus spp. Electron microscopy did not reveal viral particles in 3 examined cases. Our findings underscore the respiratory tract involvement in severe YF and could help guide diagnosis, intensive care, and public health preparedness in future outbreaks.

EID Duarte-Neto AN, Dantas KC, Ferreira SC, Giugni FR, Cunha MP, Pour SZ, et al. Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019. Emerg Infect Dis. 2026;32(2):211-224. https://doi.org/10.3201/eid3202.250530
AMA Duarte-Neto AN, Dantas KC, Ferreira SC, et al. Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019. Emerging Infectious Diseases. 2026;32(2):211-224. doi:10.3201/eid3202.250530.
APA Duarte-Neto, A. N., Dantas, K. C., Ferreira, S. C., Giugni, F. R., Cunha, M. P., Pour, S. Z....Dolhnikoff, M. (2026). Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017–2019. Emerging Infectious Diseases, 32(2), 211-224. https://doi.org/10.3201/eid3202.250530.
Dispatches

Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus [PDF - 1.58 MB - 4 pages]
H. Laurenson-Schafer et al.

We examined 89 travel-related clade Ib monkeypox virus cases detected in 33 countries during August 2024–July 2025. Most cases were among men; approximately one third led to secondary transmission. Secondary transmission risk was highest among sexual, then household, contacts. Those groups should be the focus of response strategies and interventions.

EID Laurenson-Schafer H, McMenamin M, Ebbarnezh L, Karagiannis I, Biaukula V, Lewis R, et al. Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus. Emerg Infect Dis. 2026;32(2):225-228. https://doi.org/10.3201/eid3202.251530
AMA Laurenson-Schafer H, McMenamin M, Ebbarnezh L, et al. Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus. Emerging Infectious Diseases. 2026;32(2):225-228. doi:10.3201/eid3202.251530.
APA Laurenson-Schafer, H., McMenamin, M., Ebbarnezh, L., Karagiannis, I., Biaukula, V., Lewis, R....de Waroux, O. (2026). Characteristics and Transmission Dynamics of Global Travel-Related Mpox Cases Caused by Clade Ib Monkeypox Virus. Emerging Infectious Diseases, 32(2), 225-228. https://doi.org/10.3201/eid3202.251530.

Desulfovibrio Bacteremia in Patients with Abdominal Infections, Japan, 2020–2025 [PDF - 1.40 MB - 5 pages]
N. Watanabe et al.

We reviewed 8 episodes of Desulfovibrio bacteremia in Japan (2020–2025) and confirmed 4 species by 16S rRNA gene and whole-genome sequencing. We detected β-lactamase genes in 2 D. desulfuricans (blaDES-1-like), 1 D. falkowii (blaMUN-1), and 2 D. fairfieldensis (blaCfiA-like). Mass spectometry failed to identify D. falkowii or D. legallii.

EID Watanabe N, Watari T, Otsuka Y. Desulfovibrio Bacteremia in Patients with Abdominal Infections, Japan, 2020–2025. Emerg Infect Dis. 2026;32(2):233-237. https://doi.org/10.3201/eid3202.251581
AMA Watanabe N, Watari T, Otsuka Y. Desulfovibrio Bacteremia in Patients with Abdominal Infections, Japan, 2020–2025. Emerging Infectious Diseases. 2026;32(2):233-237. doi:10.3201/eid3202.251581.
APA Watanabe, N., Watari, T., & Otsuka, Y. (2026). Desulfovibrio Bacteremia in Patients with Abdominal Infections, Japan, 2020–2025. Emerging Infectious Diseases, 32(2), 233-237. https://doi.org/10.3201/eid3202.251581.

Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum [PDF - 520 KB - 4 pages]
G. S. Long et al.

We inspected 16S rRNA sequences of 784 publicly available Treponema pallidum subspecies pallidum genomes and 17 new T. pallidum subsp. pallidum genomes from Canada for putative mutations associated with doxycycline resistance. Variants were detected in 9 non-Canada genomes. These findings establish a global genomic baseline for monitoring doxycycline resistance in syphilis.

EID Long GS, Neale M, Braukmann T, Tran V, Singh N, Allen V, et al. Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum. Emerg Infect Dis. 2026;32(2):242-245. https://doi.org/10.3201/eid3202.251060
AMA Long GS, Neale M, Braukmann T, et al. Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum. Emerging Infectious Diseases. 2026;32(2):242-245. doi:10.3201/eid3202.251060.
APA Long, G. S., Neale, M., Braukmann, T., Tran, V., Singh, N., Allen, V....Duvvuri, V. R. (2026). Genomic Analysis of Doxycycline Resistance–Associated 16S rRNA Mutations in Treponema pallidum Subspecies pallidum. Emerging Infectious Diseases, 32(2), 242-245. https://doi.org/10.3201/eid3202.251060.

Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events [PDF - 572 KB - 4 pages]
R. E. Wiegand et al.

We evaluated effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated thromboembolic events among community-dwelling Medicare fee-for-service beneficiaries >65 years of age in the United States enrolled during October 1, 2023–March 30, 2024. RSV vaccines protected against RSV-associated thromboembolic events (effectiveness 79% [95% CI 74%–83%]) in the same season as vaccine receipt.

EID Wiegand RE, Sung H, Zhang Y, Chavez A, Kautz A, Mak J, et al. Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events. Emerg Infect Dis. 2026;32(2):246-249. https://doi.org/10.3201/eid3202.251520
AMA Wiegand RE, Sung H, Zhang Y, et al. Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events. Emerging Infectious Diseases. 2026;32(2):246-249. doi:10.3201/eid3202.251520.
APA Wiegand, R. E., Sung, H., Zhang, Y., Chavez, A., Kautz, A., Mak, J....Payne, A. B. (2026). Effectiveness of RSV Vaccines against RSV-Associated Thromboembolic Events. Emerging Infectious Diseases, 32(2), 246-249. https://doi.org/10.3201/eid3202.251520.

Multiplex PCR to Differentiate Monkeypox Virus Clades [PDF - 871 KB - 5 pages]
C. T. Williams et al.

We designed a multiplex quantitative PCR to differentiate monkeypox virus clades. For clinical samples collected in the United Kingdom and Nigeria, sensitivity was 78% (95% CI 67.67%–86.14%) and specificity 94% (95% CI 80.84%–99.30%); for samples with cycle thresholds <35, sensitivity was 98% (95% CI 91.72%–99.96%) and specificity 94% (95% CI 80.84%–99.30%).

EID Williams CT, Romero-Ramirez A, Semiu A, Ifabumuyi S, Greenland-Bews C, Gould S, et al. Multiplex PCR to Differentiate Monkeypox Virus Clades. Emerg Infect Dis. 2026;32(2):250-254. https://doi.org/10.3201/eid3202.250686
AMA Williams CT, Romero-Ramirez A, Semiu A, et al. Multiplex PCR to Differentiate Monkeypox Virus Clades. Emerging Infectious Diseases. 2026;32(2):250-254. doi:10.3201/eid3202.250686.
APA Williams, C. T., Romero-Ramirez, A., Semiu, A., Ifabumuyi, S., Greenland-Bews, C., Gould, S....Edwards, T. (2026). Multiplex PCR to Differentiate Monkeypox Virus Clades. Emerging Infectious Diseases, 32(2), 250-254. https://doi.org/10.3201/eid3202.250686.

Measles Outbreak Driven by Nosocomial Transmission, Armenia, February–July 2023 [PDF - 571 KB - 4 pages]
K. Palayan et al.

During March–July 2023, we investigated a measles outbreak in Armenia. Of 287 patients, 130 were <5 years of age and 215 (75%) were unvaccinated. Among 3 transmission chains involving 183 cases, 70% of patients were exposed in healthcare facilities. To minimize nosocomial transmission, measles vaccination should be encouraged among healthcare workers.

EID Palayan K, Manukyan A, Sahakyan G, Grigoryan S, Karapetyan L, Sargsyan S, et al. Measles Outbreak Driven by Nosocomial Transmission, Armenia, February–July 2023. Emerg Infect Dis. 2026;32(2):255-258. https://doi.org/10.3201/eid3202.250474
AMA Palayan K, Manukyan A, Sahakyan G, et al. Measles Outbreak Driven by Nosocomial Transmission, Armenia, February–July 2023. Emerging Infectious Diseases. 2026;32(2):255-258. doi:10.3201/eid3202.250474.
APA Palayan, K., Manukyan, A., Sahakyan, G., Grigoryan, S., Karapetyan, L., Sargsyan, S....Stefanoff, P. (2026). Measles Outbreak Driven by Nosocomial Transmission, Armenia, February–July 2023. Emerging Infectious Diseases, 32(2), 255-258. https://doi.org/10.3201/eid3202.250474.

Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam [PDF - 2.43 MB - 6 pages]
M. Hennessey et al.

In northern Vietnam, during March 2021–March 2022, prevalence of influenza A(H9N2) in chickens was higher in distribution facilities than on farms and varied between facility types. Phylogenetic analysis indicated extensive viral mixing along networks of chicken production and distribution, highlighting a need for risk mitigation across the entire network.

EID Hennessey M, Thi T, Raghwani J, Kim Y, Pham H, Nguyen T, et al. Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam. Emerg Infect Dis. 2026;32(2):259-264. https://doi.org/10.3201/eid3202.251416
AMA Hennessey M, Thi T, Raghwani J, et al. Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam. Emerging Infectious Diseases. 2026;32(2):259-264. doi:10.3201/eid3202.251416.
APA Hennessey, M., Thi, T., Raghwani, J., Kim, Y., Pham, H., Nguyen, T....Fournié, G. (2026). Avian Influenza A(H9N2) Virus Transmission across Chicken Production and Distribution Networks, Vietnam. Emerging Infectious Diseases, 32(2), 259-264. https://doi.org/10.3201/eid3202.251416.

Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA [PDF - 2.97 MB - 5 pages]
S. Nakagun et al.

The rat lungworm, Angiostrongylus cantonensis, is an emerging veterinary and public health concern. We describe A. cantonensis infections in a zoo-housed parma wallaby and free-ranging Virginia opossums and roof rats in San Diego, California, USA. Angiostrongyliasis should be considered in central nervous system disease in humans and animals in this region.

EID Nakagun S, Gonzalez Vera CG, Wohl A, Clifford DL, Fraess GA, Nylander JR, et al. Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA. Emerg Infect Dis. 2026;32(2):265-269. https://doi.org/10.3201/eid3202.251081
AMA Nakagun S, Gonzalez Vera CG, Wohl A, et al. Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA. Emerging Infectious Diseases. 2026;32(2):265-269. doi:10.3201/eid3202.251081.
APA Nakagun, S., Gonzalez Vera, C. G., Wohl, A., Clifford, D. L., Fraess, G. A., Nylander, J. R....Burns, R. E. (2026). Autochthonous Rat Lungworm Angiostrongylus cantonensis Infections in Accidental and Definitive Hosts, San Diego, California, USA. Emerging Infectious Diseases, 32(2), 265-269. https://doi.org/10.3201/eid3202.251081.

Temporal Clustering of Mycoplasma pneumoniae–Associated Encephalitis and Stroke, South Korea, 2024 [PDF - 1.09 MB - 4 pages]
S. H. Song et al.

Seventeen pediatric encephalitis (n = 12) or stroke (n = 5) cases clustered temporally during the 2023–2024 Mycoplasma pneumoniae epidemic in South Korea; similar patterns had not been noted in previous seasons. Those findings might reflect postpandemic changes in clinical manifestation and underscore the need for neurologic surveillance during M. pneumoniae epidemics.

EID Song SH, Kang D, Kim Y, Cho J, Kim H, Kim W, et al. Temporal Clustering of Mycoplasma pneumoniae–Associated Encephalitis and Stroke, South Korea, 2024. Emerg Infect Dis. 2026;32(2):270-273. https://doi.org/10.3201/eid3202.251296
AMA Song SH, Kang D, Kim Y, et al. Temporal Clustering of Mycoplasma pneumoniae–Associated Encephalitis and Stroke, South Korea, 2024. Emerging Infectious Diseases. 2026;32(2):270-273. doi:10.3201/eid3202.251296.
APA Song, S. H., Kang, D., Kim, Y., Cho, J., Kim, H., Kim, W....Yun, K. (2026). Temporal Clustering of Mycoplasma pneumoniae–Associated Encephalitis and Stroke, South Korea, 2024. Emerging Infectious Diseases, 32(2), 270-273. https://doi.org/10.3201/eid3202.251296.

Case of Legionella pneumophila Serogroup 1 Infection Linked to Water Flosser, France [PDF - 377 KB - 3 pages]
C. Slekovec et al.

Legionnaires’ disease is a severe respiratory infection that causes increased mortality in hospitalized and immunocompromised patients. We report a nosocomial case in France linked to a water flosser. Our findings underscore the need for vigilance regarding such devices and highlight strategies for their safe management within healthcare settings.

EID Slekovec C, Biguenet A, Jeanvoine A, Hocquet D, Bertrand X. Case of Legionella pneumophila Serogroup 1 Infection Linked to Water Flosser, France. Emerg Infect Dis. 2026;32(2):274-276. https://doi.org/10.3201/eid3202.251386
AMA Slekovec C, Biguenet A, Jeanvoine A, et al. Case of Legionella pneumophila Serogroup 1 Infection Linked to Water Flosser, France. Emerging Infectious Diseases. 2026;32(2):274-276. doi:10.3201/eid3202.251386.
APA Slekovec, C., Biguenet, A., Jeanvoine, A., Hocquet, D., & Bertrand, X. (2026). Case of Legionella pneumophila Serogroup 1 Infection Linked to Water Flosser, France. Emerging Infectious Diseases, 32(2), 274-276. https://doi.org/10.3201/eid3202.251386.

Neospora caninum Infection in Marine Mammals Stranding in Northeastern Pacific Ocean Region [PDF - 777 KB - 4 pages]
S. A. Raverty et al.

We used immunohistochemistry and PCR to identify Neospora caninum in 6 infected marine mammal species, including 2 pups, that stranded in the northeastern Pacific Ocean. Our findings suggest the expansion of this parasite’s host range to marine mammals, underscoring the effect of terrestrial pathogens that flow from land to sea.

EID Raverty SA, Duignan P, Lambourn DM, Cottrell P, Gill VA, Tuomi P, et al. Neospora caninum Infection in Marine Mammals Stranding in Northeastern Pacific Ocean Region. Emerg Infect Dis. 2026;32(2):277-280. https://doi.org/10.3201/eid3202.251507
AMA Raverty SA, Duignan P, Lambourn DM, et al. Neospora caninum Infection in Marine Mammals Stranding in Northeastern Pacific Ocean Region. Emerging Infectious Diseases. 2026;32(2):277-280. doi:10.3201/eid3202.251507.
APA Raverty, S. A., Duignan, P., Lambourn, D. M., Cottrell, P., Gill, V. A., Tuomi, P....Grigg, M. E. (2026). Neospora caninum Infection in Marine Mammals Stranding in Northeastern Pacific Ocean Region. Emerging Infectious Diseases, 32(2), 277-280. https://doi.org/10.3201/eid3202.251507.

Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025 [PDF - 498 KB - 4 pages]
A. Truffot et al.

We report 2 cases of donor-derived West Nile virus infection in kidney transplant recipients in France. Both recipients had mild disease develop and recovered without sequelae. A more proactive screening strategy in France, particularly during periods of highest risk for West Nile virus circulation, would help reduce risk for donor-derived infections.

EID Truffot A, Montcuquet A, Grard G, Pezzi L, Klitting R, Clavel G, et al. Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025. Emerg Infect Dis. 2026;32(2):281-284. https://doi.org/10.3201/eid3202.251569
AMA Truffot A, Montcuquet A, Grard G, et al. Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025. Emerging Infectious Diseases. 2026;32(2):281-284. doi:10.3201/eid3202.251569.
APA Truffot, A., Montcuquet, A., Grard, G., Pezzi, L., Klitting, R., Clavel, G....Morand, P. (2026). Donor-Derived West Nile Virus Infection in Kidney Transplant Recipients, France, 2025. Emerging Infectious Diseases, 32(2), 281-284. https://doi.org/10.3201/eid3202.251569.

Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025 [PDF - 801 KB - 4 pages]
N. N. Tarbuck et al.

US retail milk monitoring during April 13–May 3, 2024, identified influenza A(H5N1) viral RNA in 36% of retail milk samples, indicating widespread undetected infections in US dairy cows. After federal initiatives, reported infections more closely aligned with findings in retail milk during December 27, 2024–January 29, 2025, reflecting improved detection and control.

EID Tarbuck NN, Franks J, Jones JC, Kandeil A, DeBeauchamp J, Miller L, et al. Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025. Emerg Infect Dis. 2026;32(2):238-241. https://doi.org/10.3201/eid3202.251332
AMA Tarbuck NN, Franks J, Jones JC, et al. Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025. Emerging Infectious Diseases. 2026;32(2):238-241. doi:10.3201/eid3202.251332.
APA Tarbuck, N. N., Franks, J., Jones, J. C., Kandeil, A., DeBeauchamp, J., Miller, L....Bowman, A. S. (2026). Retail Milk Monitoring of Influenza A(H5N1) in Dairy Cattle, United States, 2024–2025. Emerging Infectious Diseases, 32(2), 238-241. https://doi.org/10.3201/eid3202.251332.

Rabies Reemergence, Central Europe, 2022–2024 [PDF - 1.05 MB - 4 pages]
E. Robardet et al.

Oral rabies vaccination campaigns helped eliminate rabies from parts of Europe, but rabies appears to be reemerging. We analyzed 2022–2024 data, which demonstrated reemergence of 2 virus variants; both were detected in Ukraine, Moldova, Poland, and Romania. Our findings highlight the need to strengthen rabies control efforts in the region.

EID Robardet E, Smreczak M, Orłowska A, Malik P, Nándori A, Dirbáková Z, et al. Rabies Reemergence, Central Europe, 2022–2024. Emerg Infect Dis. 2026;32(2):229-232. https://doi.org/10.3201/eid3202.251597
AMA Robardet E, Smreczak M, Orłowska A, et al. Rabies Reemergence, Central Europe, 2022–2024. Emerging Infectious Diseases. 2026;32(2):229-232. doi:10.3201/eid3202.251597.
APA Robardet, E., Smreczak, M., Orłowska, A., Malik, P., Nándori, A., Dirbáková, Z....Picard-Meyer, E. (2026). Rabies Reemergence, Central Europe, 2022–2024. Emerging Infectious Diseases, 32(2), 229-232. https://doi.org/10.3201/eid3202.251597.
Research Letters

Severe Respiratory Diphtheria-Like Illness Caused by Toxigenic Corynebacterium ulcerans [PDF - 600 KB - 3 pages]
R. Helleren et al.

We report a possible zoonotic case of severe diphtheria-like respiratory illness in Norway caused by a previously unreported toxigenic Corynebacterium ulcerans sequence type. This case highlights C. ulcerans as an emerging pathogen that can cause life-threatening disease. Clinicians should be aware of C. ulcerans infection, even in regions where diphtheria is rare.

EID Helleren R, Fløystad H, Tellefsen O, Boskovic M, Skraastad T, Mengshoel A, et al. Severe Respiratory Diphtheria-Like Illness Caused by Toxigenic Corynebacterium ulcerans. Emerg Infect Dis. 2026;32(2):285-287. https://doi.org/10.3201/eid3202.250908
AMA Helleren R, Fløystad H, Tellefsen O, et al. Severe Respiratory Diphtheria-Like Illness Caused by Toxigenic Corynebacterium ulcerans. Emerging Infectious Diseases. 2026;32(2):285-287. doi:10.3201/eid3202.250908.
APA Helleren, R., Fløystad, H., Tellefsen, O., Boskovic, M., Skraastad, T., Mengshoel, A....Skogen, V. (2026). Severe Respiratory Diphtheria-Like Illness Caused by Toxigenic Corynebacterium ulcerans. Emerging Infectious Diseases, 32(2), 285-287. https://doi.org/10.3201/eid3202.250908.

Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment [PDF - 305 KB - 3 pages]
L. Rojek et al.

We describe acute severe hepatitis B virus (HBV) infection with liver failure requiring transplantation in a patient in Poland treated with acalabrutinib. The patient was fully vaccinated against HBV and had adequate HBV antibody titers and no HBV exposure documented before therapy. Differential diagnoses for jaundice should consider HBV in patients receiving acalabrutunib.

EID Rojek L, Wnuk-Lipinski T, Marek I, Grabowski H, Adrych K. Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. Emerg Infect Dis. 2026;32(2):287-289. https://doi.org/10.3201/eid3202.251111
AMA Rojek L, Wnuk-Lipinski T, Marek I, et al. Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. Emerging Infectious Diseases. 2026;32(2):287-289. doi:10.3201/eid3202.251111.
APA Rojek, L., Wnuk-Lipinski, T., Marek, I., Grabowski, H., & Adrych, K. (2026). Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. Emerging Infectious Diseases, 32(2), 287-289. https://doi.org/10.3201/eid3202.251111.

Invasive Pneumococcal Disease among Childbearing-Age Women, United States, 2007–2023 [PDF - 637 KB - 4 pages]
N. Prasad et al.

US data on invasive pneumococcal disease incidence among pregnant and postpartum women are limited. We estimated incidence in those groups using population-based surveillance. Compared with nonpregnant women of childbearing age, incidence was similar for pregnant women but 3.5 times higher for postpartum women. Our findings could inform pneumococcal vaccine recommendations.

EID Prasad N, Chochua S, Anderson BJ, Angeles KM, Barnes M, Harrison LH, et al. Invasive Pneumococcal Disease among Childbearing-Age Women, United States, 2007–2023. Emerg Infect Dis. 2026;32(2):290-293. https://doi.org/10.3201/eid3202.251279
AMA Prasad N, Chochua S, Anderson BJ, et al. Invasive Pneumococcal Disease among Childbearing-Age Women, United States, 2007–2023. Emerging Infectious Diseases. 2026;32(2):290-293. doi:10.3201/eid3202.251279.
APA Prasad, N., Chochua, S., Anderson, B. J., Angeles, K. M., Barnes, M., Harrison, L. H....Kobayashi, M. (2026). Invasive Pneumococcal Disease among Childbearing-Age Women, United States, 2007–2023. Emerging Infectious Diseases, 32(2), 290-293. https://doi.org/10.3201/eid3202.251279.

Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024 [PDF - 327 KB - 3 pages]
C. Trombetta et al.

We conducted a multicenter study in Europe (France, Italy, and Ukraine) to assess the seroprevalence of influenza D virus (IDV) in domestic cats and dogs. Serum samples from France (2015–2018) and Italy (2023–2024) showed no IDV positivity. In Ukraine, 2.46% of dogs and 0.85% of cats tested IDV-positive in 2024.

EID Trombetta C, Fiori A, Falsini A, Pellegrini F, Le Poder S, Eichenbaum A, et al. Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024. Emerg Infect Dis. 2026;32(2):293-295. https://doi.org/10.3201/eid3202.251164
AMA Trombetta C, Fiori A, Falsini A, et al. Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024. Emerging Infectious Diseases. 2026;32(2):293-295. doi:10.3201/eid3202.251164.
APA Trombetta, C., Fiori, A., Falsini, A., Pellegrini, F., Le Poder, S., Eichenbaum, A....Camero, M. (2026). Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024. Emerging Infectious Diseases, 32(2), 293-295. https://doi.org/10.3201/eid3202.251164.

Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022 [PDF - 1.56 MB - 5 pages]
B. Armson et al.

Vesicular disease caused by Seneca Valley virus infection occurred in pigs from 5 outdoor pig farms in England during June–September 2022. Clinical signs resembled notifiable vesicular diseases, such as foot-and-mouth disease. Full genome sequences shared a common ancestor with a virus circulating in the United States.

EID Armson B, Mioulet V, Wood BA, Di Nardo A, Knowles NJ, Wadsworth J, et al. Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022. Emerg Infect Dis. 2026;32(2):295-299. https://doi.org/10.3201/eid3202.251194
AMA Armson B, Mioulet V, Wood BA, et al. Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022. Emerging Infectious Diseases. 2026;32(2):295-299. doi:10.3201/eid3202.251194.
APA Armson, B., Mioulet, V., Wood, B. A., Di Nardo, A., Knowles, N. J., Wadsworth, J....King, D. P. (2026). Vesicular Disease Caused by Seneca Valley Virus in Pigs, England, 2022. Emerging Infectious Diseases, 32(2), 295-299. https://doi.org/10.3201/eid3202.251194.

Vaccine-Like African Swine Fever Virus Strain in Domestic Pigs, Thailand, 2024 [PDF - 781 KB - 4 pages]
T. Nguyen et al.

African swine fever virus genotype II is endemic in Thailand, typically causing acute disease. We investigated a vaccine-like strain, characterized by 6 multigene family gene deletions, from nonvaccinated herds. We found this strain was associated with chronic disease in pigs.

EID Nguyen T, Venkateswaran D, Prakash A, Nguyen Q, Suntisukwattana R, Jongkaewwattana A, et al. Vaccine-Like African Swine Fever Virus Strain in Domestic Pigs, Thailand, 2024. Emerg Infect Dis. 2026;32(2):299-302. https://doi.org/10.3201/eid3202.251245
AMA Nguyen T, Venkateswaran D, Prakash A, et al. Vaccine-Like African Swine Fever Virus Strain in Domestic Pigs, Thailand, 2024. Emerging Infectious Diseases. 2026;32(2):299-302. doi:10.3201/eid3202.251245.
APA Nguyen, T., Venkateswaran, D., Prakash, A., Nguyen, Q., Suntisukwattana, R., Jongkaewwattana, A....Nilubol, D. (2026). Vaccine-Like African Swine Fever Virus Strain in Domestic Pigs, Thailand, 2024. Emerging Infectious Diseases, 32(2), 299-302. https://doi.org/10.3201/eid3202.251245.

Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom [PDF - 693 KB - 4 pages]
V. H. Sheridan et al.

A 2-dose regimen of the vaccine modified vaccinia Ankara–Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for monkeypox virus clade Ib as well as for clade IIb.

EID Sheridan VH, Duffy CW, Dunning J, Turtle L, Hiscox JA, Subramaniam KS. Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. Emerg Infect Dis. 2026;32(2):302-305. https://doi.org/10.3201/eid3202.251553
AMA Sheridan VH, Duffy CW, Dunning J, et al. Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. Emerging Infectious Diseases. 2026;32(2):302-305. doi:10.3201/eid3202.251553.
APA Sheridan, V. H., Duffy, C. W., Dunning, J., Turtle, L., Hiscox, J. A., & Subramaniam, K. S. (2026). Monkeypox Virus Antibodies in Healthy Persons after Vaccination with MVA-BN, United Kingdom. Emerging Infectious Diseases, 32(2), 302-305. https://doi.org/10.3201/eid3202.251553.

Airport Malaria Cluster in Certified Malaria-Free Country, Libya, 2024 [PDF - 511 KB - 3 pages]
A. M. Alarbi et al.

In November 2024, an autochthonous cluster of 4 Plasmodium falciparum cases (1 fatal) was identified near Benina International Airport, Benghazi, Libya. Epidemiologic and entomologic investigation ruled out local transmission, pointing to airport malaria as the cause and highlighting the vulnerability of malaria-free regions to imported vectors.

EID Alarbi AM, Elhaddad AB, Almehdawi NM, Saadawi WK, Aqeehal H, Elalem M. Airport Malaria Cluster in Certified Malaria-Free Country, Libya, 2024. Emerg Infect Dis. 2026;32(2):305-307. https://doi.org/10.3201/eid3202.251508
AMA Alarbi AM, Elhaddad AB, Almehdawi NM, et al. Airport Malaria Cluster in Certified Malaria-Free Country, Libya, 2024. Emerging Infectious Diseases. 2026;32(2):305-307. doi:10.3201/eid3202.251508.
APA Alarbi, A. M., Elhaddad, A. B., Almehdawi, N. M., Saadawi, W. K., Aqeehal, H., & Elalem, M. (2026). Airport Malaria Cluster in Certified Malaria-Free Country, Libya, 2024. Emerging Infectious Diseases, 32(2), 305-307. https://doi.org/10.3201/eid3202.251508.
Emerging Infection Networks Letter

Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023 [PDF - 321 KB - 3 pages]
J. E. Laury et al.

During 2022–2023, the Antimicrobial Resistance Laboratory Network tested 8,033 Candida auris clinical isolates in the United States. Overall, 95% of isolates were fluconazole resistant, 15% amphotericin B resistant, and 1% echinocandin resistant. Laboratory capacity for C. auris identification and antifungal susceptibility testing is essential to address this emerging public health threat.

EID Laury JE, Forsberg K, Berkow EL, Jones S, Sexton D, Sievert DM, et al. Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023. Emerg Infect Dis. 2026;32(2):308-310. https://doi.org/10.3201/eid3202.251043
AMA Laury JE, Forsberg K, Berkow EL, et al. Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023. Emerging Infectious Diseases. 2026;32(2):308-310. doi:10.3201/eid3202.251043.
APA Laury, J. E., Forsberg, K., Berkow, E. L., Jones, S., Sexton, D., Sievert, D. M....Lyman, M. (2026). Candida auris Testing by the Antimicrobial Resistance Laboratory Network, United States, 2022–2023. Emerging Infectious Diseases, 32(2), 308-310. https://doi.org/10.3201/eid3202.251043.
Etymologia

Mumps [muhmps] [PDF - 349 KB - 1 page]
S. Mohan and A. Khan
EID Mohan S, Khan A. Mumps [muhmps]. Emerg Infect Dis. 2026;32(2):258. https://doi.org/10.3201/eid3202.240153
AMA Mohan S, Khan A. Mumps [muhmps]. Emerging Infectious Diseases. 2026;32(2):258. doi:10.3201/eid3202.240153.
APA Mohan, S., & Khan, A. (2026). Mumps [muhmps]. Emerging Infectious Diseases, 32(2), 258. https://doi.org/10.3201/eid3202.240153.
Corrections

Correction: Vol. 32, No. 1 [PDF - 175 KB - 1 page]
EID Correction: Vol. 32, No. 1. Emerg Infect Dis. 2026;32(2):310. https://doi.org/10.3201/eid3202.c13202
AMA Correction: Vol. 32, No. 1. Emerging Infectious Diseases. 2026;32(2):310. doi:10.3201/eid3202.c13202.
APA (2026). Correction: Vol. 32, No. 1. Emerging Infectious Diseases, 32(2), 310. https://doi.org/10.3201/eid3202.c13202.
About the Cover

Yellow Fever in Buenos Aires [PDF - 1.39 MB - 3 pages]
T. Chorba
EID Chorba T. Yellow Fever in Buenos Aires. Emerg Infect Dis. 2026;32(2):311-313. https://doi.org/10.3201/eid3202.ac3202
AMA Chorba T. Yellow Fever in Buenos Aires. Emerging Infectious Diseases. 2026;32(2):311-313. doi:10.3201/eid3202.ac3202.
APA Chorba, T. (2026). Yellow Fever in Buenos Aires. Emerging Infectious Diseases, 32(2), 311-313. https://doi.org/10.3201/eid3202.ac3202.
Page created: February 15, 2026
Page updated: February 20, 2026
Page reviewed: February 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external